rs1051421

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000214.3(JAG1):​c.3528C>T​(p.Tyr1176=) variant causes a synonymous change. The variant allele was found at a frequency of 0.253 in 1,614,010 control chromosomes in the GnomAD database, including 53,389 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 4229 hom., cov: 33)
Exomes 𝑓: 0.26 ( 49160 hom. )

Consequence

JAG1
NM_000214.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 5.44
Variant links:
Genes affected
JAG1 (HGNC:6188): (jagged canonical Notch ligand 1) The jagged 1 protein encoded by JAG1 is the human homolog of the Drosophilia jagged protein. Human jagged 1 is the ligand for the receptor notch 1, the latter is involved in signaling processes. Mutations that alter the jagged 1 protein cause Alagille syndrome. Jagged 1 signalling through notch 1 has also been shown to play a role in hematopoiesis. [provided by RefSeq, Nov 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 20-10639627-G-A is Benign according to our data. Variant chr20-10639627-G-A is described in ClinVar as [Benign]. Clinvar id is 42478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-10639627-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.277 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
JAG1NM_000214.3 linkuse as main transcriptc.3528C>T p.Tyr1176= synonymous_variant 26/26 ENST00000254958.10 NP_000205.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
JAG1ENST00000254958.10 linkuse as main transcriptc.3528C>T p.Tyr1176= synonymous_variant 26/261 NM_000214.3 ENSP00000254958 P1P78504-1
JAG1ENST00000423891.6 linkuse as main transcriptn.3394C>T non_coding_transcript_exon_variant 24/252

Frequencies

GnomAD3 genomes
AF:
0.222
AC:
33775
AN:
152058
Hom.:
4232
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.109
Gnomad AMI
AF:
0.466
Gnomad AMR
AF:
0.284
Gnomad ASJ
AF:
0.287
Gnomad EAS
AF:
0.155
Gnomad SAS
AF:
0.191
Gnomad FIN
AF:
0.216
Gnomad MID
AF:
0.269
Gnomad NFE
AF:
0.278
Gnomad OTH
AF:
0.256
GnomAD3 exomes
AF:
0.243
AC:
61006
AN:
251472
Hom.:
7968
AF XY:
0.244
AC XY:
33122
AN XY:
135904
show subpopulations
Gnomad AFR exome
AF:
0.104
Gnomad AMR exome
AF:
0.277
Gnomad ASJ exome
AF:
0.300
Gnomad EAS exome
AF:
0.145
Gnomad SAS exome
AF:
0.192
Gnomad FIN exome
AF:
0.222
Gnomad NFE exome
AF:
0.279
Gnomad OTH exome
AF:
0.257
GnomAD4 exome
AF:
0.256
AC:
373983
AN:
1461834
Hom.:
49160
Cov.:
35
AF XY:
0.256
AC XY:
185971
AN XY:
727220
show subpopulations
Gnomad4 AFR exome
AF:
0.102
Gnomad4 AMR exome
AF:
0.273
Gnomad4 ASJ exome
AF:
0.296
Gnomad4 EAS exome
AF:
0.173
Gnomad4 SAS exome
AF:
0.195
Gnomad4 FIN exome
AF:
0.221
Gnomad4 NFE exome
AF:
0.269
Gnomad4 OTH exome
AF:
0.245
GnomAD4 genome
AF:
0.222
AC:
33770
AN:
152176
Hom.:
4229
Cov.:
33
AF XY:
0.220
AC XY:
16333
AN XY:
74402
show subpopulations
Gnomad4 AFR
AF:
0.108
Gnomad4 AMR
AF:
0.284
Gnomad4 ASJ
AF:
0.287
Gnomad4 EAS
AF:
0.155
Gnomad4 SAS
AF:
0.191
Gnomad4 FIN
AF:
0.216
Gnomad4 NFE
AF:
0.278
Gnomad4 OTH
AF:
0.257
Alfa
AF:
0.269
Hom.:
9187
Bravo
AF:
0.221
Asia WGS
AF:
0.169
AC:
590
AN:
3478
EpiCase
AF:
0.284
EpiControl
AF:
0.282

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 30, 2016p.Tyr1176Tyr in exon 26 of JAG1: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 28% (18682/66732) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac. broadinstitute.org; dbSNP rs1051421). -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpApr 04, 2023- -
Alagille syndrome due to a JAG1 point mutation Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 19, 2021- -
Isolated Nonsyndromic Congenital Heart Disease Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Deafness, congenital heart defects, and posterior embryotoxon Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 19, 2021- -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Tetralogy of Fallot Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 19, 2021- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 24, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
7.8
DANN
Benign
0.95
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1051421; hg19: chr20-10620275; COSMIC: COSV54754834; COSMIC: COSV54754834; API